Optimizerx Corp(OPRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low5.89
Day High6.39
Open:6.16
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
GlobeNewswire
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
Tipranks
OptimizeRx Shareholders Expand Equity Plan, Maintain Oversight
Tipranks
OptimizeRx Announces Chief Commercial Officer Transition Agreement
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
Zacks Investment Research
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
GlobeNewswire
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
Zacks Investment Research
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
Tipranks
OptimizeRx Earnings Call Balances Growth Hopes and Strains
Motley Fool
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
Tipranks
B. Riley Securities Remains a Buy on OptimizeRx (OPRX)
Tipranks
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), ProQR (PRQR) and OptimizeRx (OPRX)
Tipranks
OptimizeRx Secures New Credit Facility to Boost Flexibility
MarketBeat
OptimizeRx Q1 Earnings Call Highlights
MarketBeat.com
GlobeNewswire
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Tipranks
Lake Street Sticks to Its Buy Rating for OptimizeRx (OPRX)
GlobeNewswire
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Zacks Investment Research
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
GlobeNewswire
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

Profile

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.